Rare and Orphan Diseases

joint efforts will form best practices for non-profit health organizations to leverage patient self-reporting with the goal of advancing science, treatment and quality of life.

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Gil Bashe, Medika Life Editor - June 18, 2025

I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked a watershed moment in medicine:...

Real-World Evidence Unlocks Consumer Voice to Improve Care

Gil Bashe, Medika Life Editor - January 15, 2025

Patient Experience is the Key to Improving Drug Development and Health Care, but Are We Listening?

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Gil Bashe, Medika Life Editor - October 21, 2024

EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Real-World Evidence Unlocks Consumer Voice to Improve Care

2024 Health Trends: Progress, Challenges, and Opportunities

LATEST

TRENDING

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Rare – Always Present and Never Forgotten

The Disorder That Makes Monster Faces Out of Everyone You See

Looking for Zebras: Listening to Patients, Healing the Health System

2024 Health Trends: Progress, Challenges, and Opportunities

Real-World Evidence Unlocks Consumer Voice to Improve Care

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Hair Loss: The Hidden Toll of Stress

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

EDITORS CHOICE

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Real-World Evidence Unlocks Consumer Voice to Improve Care

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories